Cell migration to injury sites

Cell migration to injury sites is a coordinated biological response involving diverse cell types (e.g., neutrophils, monocytes, fibroblasts, epithelial cells) that move toward damaged tissue after injury. This process is orchestrated by a variety of molecular signals—including chemokines, cytokines, DAMPs (damage-associated molecular patterns), and bioactive lipids—which bind to surface receptors such as chemokine receptors (e.g., CCR2), G protein-coupled receptors (GPCRs), integrins, and purinergic receptors (e.g., P2Y2). These pathways activate cytoskeletal rearrangements and direct cell movement to the injury site to promote inflammation, tissue repair, and regeneration[1][4][6][7]. “Cell migration to injury sites” is not a single molecule or receptor, but a complex, multi-step process involving many targets and mechanisms. If your workflow requires a canonical molecular target, several specific molecules are central in mediating migration (e.g., CCR2, CXCR2, EGFR, N-cadherin, P2Y2 receptor), but “cell migration to injury sites” is not itself a valid molecular target entry[1][6][4]. Drugs can indirectly affect this process by modulating these individual targets, but there is no drug that binds or directly modulates “cell migration to injury sites” as an entity.

Other names

wound-directed cell migrationinjury-induced cell migrationmigration to wound sites